The non-pseudo gene version of MLLT10 has been documented to be a promoter of tumor cell proliferation, migration, and invasion in NSCLC cell lines (83), and MLLT10P1 is commonly mutated in breast cancer patients (84). This evidence concerns the gene MLLT10P1 and non-small cell lung carcinoma.